Impact Biomedical IBO
NYSE IBO
$0.48 +0.03 (+6.83%)
As of: Aug 21, 2026 · 2:19 PM EDT

Impact Biomedical (IBO) Revenue Growth (1y) (2026)

Impact Biomedical (IBO) Revenue Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 12.45%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 16.73%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 59.71%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.11%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 29.63%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 66.86%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -99.97%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 296.11%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 16.50%
10 Impact Biomedical 49.54 Mn 49.53 Mn 2,000.00 -57.14%

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.14%